Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
58,027
-
Shares change
-
+58,027
-
Total reported value, excl. options
-
$39,187
-
Value change
-
+$39,188
-
Number of buys
-
9
-
Price
-
$1
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q2 2024
9 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q2 2024.
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58,027 shares
.
Largest 10 shareholders include ACADIAN ASSET MANAGEMENT LLC (57,762 shares), MORGAN STANLEY (251 shares), JPMORGAN CHASE & CO (7 shares), Global Retirement Partners, LLC (2 shares), Allworth Financial LP (1 shares), Planning Capital Management Corp (1 shares), BlackRock Inc. (1 shares), Activest Wealth Management (1 shares), CENTRAL TRUST Co (1 shares), and PRUDENTIAL FINANCIAL INC (97,707 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.